Arteriovenous Metabolomics to Measure In Vivo Metabolite Exchange in Brown Adipose Tissue
October 6th, 2023
In this protocol, methods relevant for BAT-optimized arteriovenous metabolomics using GC-MS in a mouse model are outlined. These methods allow for the acquisition of valuable insights into BAT-mediated metabolite exchange at the organismal level.
Our lab is interested in identifying mechanisms by which signaling pathways and metabolic pathways collaborate to regulate adipose tissue metabolism and physiology. And through that approach, we aim to find a way to prevent or target metabolic diseases caused by energy imbalances such as obesity and diabetes. The major advantage of our protocol is we have shifted from the conventional rat model to using a mouse model for arterial venous blood sampling and metabolomic analysis.
We believe that this transition will allow us to validate our findings using the gold standard genetic models more rapidly for brown fat research.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol outlines methods for BAT-optimized arteriovenous metabolomics using GC-MS in a mouse model. These methods provide insights into BAT-mediated metabolite exchange at the organismal level.
Key Study Components
Area of Science
- Neuroscience
- Metabolomics
- Adipose Tissue Research
Background
- Understanding the collaboration between signaling and metabolic pathways is crucial for regulating adipose tissue metabolism.
- Targeting metabolic diseases like obesity and diabetes is a primary research goal.
- Transitioning from rat to mouse models enhances the validation of findings.
- Mouse models allow for more rapid testing of genetic models in brown fat research.
Purpose of Study
- To identify mechanisms regulating adipose tissue metabolism.
- To prevent or target metabolic diseases caused by energy imbalances.
- To validate findings using gold standard genetic models.
Methods Used
- GC-MS for metabolomic analysis.
- Arteriovenous blood sampling in a mouse model.
- Comparison of findings with conventional rat models.
- Focus on brown adipose tissue (BAT) research.
Main Results
- Insights into BAT-mediated metabolite exchange were obtained.
- Validation of findings was achieved using mouse models.
- Enhanced understanding of metabolic pathways in adipose tissue.
- Potential implications for targeting obesity and diabetes.
Conclusions
- The protocol provides a robust method for studying BAT metabolism.
- Mouse models offer significant advantages for metabolic research.
- Findings contribute to the understanding of energy balance and metabolic diseases.
Frequently Asked Questions
Executive Industry Relevance
Arteriovenous metabolomics in brown adipose tissue (BAT) enables direct quantification of metabolite exchange, supporting mechanistic de-risking in metabolic disease research. This approach enhances predictive confidence in target validation by measuring in vivo nutrient uptake and release, informing early discovery and translational strategies. The protocol's adaptation to mouse models accelerates genetic validation and portfolio triage for metabolic targets.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct measurement of BAT-mediated metabolite flux for functional target validation.
- Supports mechanistic de-risking by clarifying nutrient utilization and secretion pathways in vivo.
- Facilitates rapid hypothesis testing using genetically tractable mouse models.
Screening & Assay Development
- Provides validated biological readouts for downstream metabolic screening workflows.
- Delivers quantitative metabolite profiles to standardize assay development and reproducibility.
- Enables platform reuse for comparative studies across metabolic interventions.
Translational & Preclinical Research
- Aligns with disease-relevant models for translational biomarker discovery in metabolic disorders.
- Supports continuity from early discovery through preclinical validation of metabolic targets.
- Informs risk-adjusted advancement decisions by quantifying systemic metabolite exchange.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by enabling in vivo metabolic flux analysis in mouse models, bridging early target validation and translational research.
- Discovery Biology: Quantifies BAT-specific metabolite uptake and release to clarify metabolic pathway engagement.
- Screening: Supplies reproducible, quantitative metabolomics data for assay readiness and compound evaluation.
- Analytics: Provides high-resolution GC-MS outputs for comparative metabolic analysis across conditions.
- Translational Research: Connects mechanistic findings to systemic metabolic phenotypes relevant to disease models.
- Enterprise Reuse: Establishes a reusable platform for metabolic flux studies in genetically modified mouse lines.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in metabolic target validation.
- Operational Value: Standardizes in vivo metabolite exchange measurements for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early de-risking of metabolic targets.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of metabolic disease programs.
Implementation Considerations
- Requires expertise in mouse surgical techniques and arteriovenous blood sampling.
- Demands access to GC-MS instrumentation and metabolomics analytical infrastructure.
- Necessitates cross-team standardization for sample collection and data analysis.
- Adaptation may be needed for different adipose depots or metabolic models.
- Practical limitations include technical complexity and sample throughput constraints.
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg%3Fv%3D2026-07-08T02%253A25%253A48.878Z&w=384&q=75)
